Article
Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey.
Cancer genetics - 1 Apr 2022
Bora Elcin, Caglayan Ahmet Okay, Koc Altug, Cankaya Tufan, Ozkalayci Hande, Kocabey Mehmet, Kemer Demet, Aksoy Suleyman, Alicikus Zumre Arican, Akin Isil Basara, Durak Merih Guray, Gurel Duygu, Yavuzsen Tugba, Sevinc Ali, Somali Isil, Gorken Ilknur, Balci Pinar, Karaoglu Aziz, Saydam Serdar, Ulgenalp Ayfer
Abstract excerpt
Breast cancer, a worldwide leading cause of cancer in women, may occur in familial cases. Germline mutations in BRCA1/2 genes are responsible for 15% of the familial cases. With the power of next generation sequencing (NGS) analysis, it is possible to analyze genes related to hereditary susceptibility to breast cancer and investigate the genetic etiology more thoroughly. In this study, we investigated 30 genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
